79
Participants
Start Date
July 1, 2016
Primary Completion Date
August 16, 2019
Study Completion Date
August 16, 2019
Cannabidiol
The investigators will carry out a double-blind, randomized, controlled trial comparing the effects of 92 days of 400 (only for the first 2 Days starting on the Day 2 of the study) or 800 mg CBD (subjects who report side effects with the 800mg dose will be administered the CBD 400 mg dose for the remainder of the trial) vs. placebo administration on cocaine craving and relapse in 110 cocaine-dependent subjects.
Centre de recherche du Centre Hospitalier de l'Université de Montréal, Montreal
Centre hospitalier de l'Université de Montréal (CHUM)
OTHER